In this episode, Dr. Kirstie Keller, CEO of Additional Ventures, shares how a bold, mission-driven approach is transforming research and innovation in single ventricle heart disease. She discusses the shift from fragmented efforts to a coordinated ecosystem—leveraging AI, data integration, and targeted investment to accelerate progress toward a cure. The conversation highlights the need for collective funding, cross-sector collaboration, and a redefinition of pediatrics as a true frontier for...